Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Paliperidone palmitate prolonged release suspension for injection

Brand: Xeplion®
NICE TA: 
Indication: Maintenance treatment of schizophrenia in adult patients
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

Paliperidone palmitate is recommended as a treatment option for the maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone and in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed where both of the following criteria are met;
• where treatment is in line with the recommendations within NICE CG178 for the use of depot or long-acting injectable antipsychotic medication and
• where treatment is in line with the Lancashire Care Guidance for Prescribing Second Generation Long Acting Antipsychotic Injections

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red